FDA Inspection 885391 — Titan Medical Enterprises, Inc. DBA U.S. Apothecary Labs

Titan Medical Enterprises, Inc. DBA U.S. Apothecary Labs — FEI 1000125216

The FDA completed an inspection of Titan Medical Enterprises, Inc. DBA U.S. Apothecary Labs on June 16, 2014 in Santa Fe Springs, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 19 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 16, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Fe Springs, CA (United States)

Citations

IDCFRDescription
125621 CFR 211.68(b)Backup file not maintained
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
1553321 CFR 111.255(c)Batch record - follow master
1553421 CFR 111.255(c)Batch record - each step
1583921 CFR 111.70(e)Specifications - identity, purity, strength, composition
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
1586121 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
1587121 CFR 111.75(c)(2)Specifications met - test, examinations; compliance
1588221 CFR 111.75(h)Tests, examinations - scientifically valid
1590821 CFR 111.90(b)(1)Reprocessed, dietary supplement - no material review
1595421 CFR 111.113(a)(2)Quality control master manufacturing record; material review, disposition
203121 CFR 211.194(a)Complete test data included in records
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360321 CFR 211.160(b)Scientifically sound laboratory controls
361021 CFR 211.160(b)(3)Drug product sample
430321 CFR 211.67(b)Written procedures fail to include
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.